A remarkable body of evidence links the zonulin-induced loss in small intestinal barrier function with diabetes mellitus, as elevated serum or fecal zonulin levels may predict the onset of the disease and shows correlation with poor glycaemic control in type 1 (T1D) [137,138,139] and type 2 (T2D) diabetes patients [69,140]. Here, HP is linked to diabetes mellitus.